@misc
{TN_libero_mab2,
author = {
Kondo, Takayuki
AND
Banno, Haruhiko
AND
Okunomiya, Taro
AND
Amino, Yoko
AND
Endo, Kayoko
AND
Nakakura, Akiyoshi
AND
Uozumi, Ryuji
AND
Kinoshita, Akemi
AND
Tada, Harue
AND
Morita, Satoshi
AND
Ishikawa, Hidehiro
AND
Shindo, Akihiro
AND
Yasuda, Ken
AND
Taruno, Yosuke
AND
Maki, Takakuni
AND
Suehiro, Takashi
AND
Mori, Kohji
AND
Ikeda, Manabu
AND
Fujita, Koji
AND
Izumi, Yuishin
AND
Kanemaru, Kazutomi
AND
Ishii, Kenji
AND
Shigenobu, Kazue
AND
Kutoku, Yumiko
AND
Sunada, Yoshihide
AND
Kawakatsu, Shinobu
AND
Shiota, Shunji
AND
Watanabe, Toshifumi
AND
Uchikawa, Osamu
AND
Takahashi, Ryosuke
AND
Tomimoto, Hidekazu
AND
Inoue, Haruhisa
},
title = {
Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations
},
publisher = {BMJ},
isbn = {2044-6055},
keywords = {
General Medicine
},
year = {2021},
url = {
http://slubdd.de/katalog?TN_libero_mab2
}
}